Monoclonal antibody AK002
Term · Oncology and biomedicine · MLC-T-ONC-015252
A therapeutic monoclonal antibody against an as-of-yet unidentified target expressed on mast cells and eosinophils. Upon administration, AK002 targets and binds to a receptor expressed on the surface of mast cells and eosinophils. This may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against cells overexpressing the undisclosed receptor. This may reduce abnormal proliferation of mast cells and eosinophils, which play a key role in allergic and inflammatory responses.
| Identifier | MLC-T-ONC-015252 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | monoclonal antibody AK 002 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015252",
"term": "Monoclonal antibody AK002",
"field": "Oncology and biomedicine",
"definition": "A therapeutic monoclonal antibody against an as-of-yet unidentified target expressed on mast cells and eosinophils. Upon administration, AK002 targets and binds to a receptor expressed on the surface of mast cells and eosinophils. This may induce antibody-dependent cell-mediated cytotoxicity (ADCC) against cells overexpressing the undisclosed receptor. This may reduce abnormal proliferation of mast cells and eosinophils, which play a key role in allergic and inflammatory responses.",
"synonyms": [
"monoclonal antibody AK 002"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/monoclonal-antibody-ak002/"
}
Record 11,227 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.